Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists use High-Tech scans to spy on prostate Cancer's secrets

NCT ID NCT07302763

Summary

This study aims to understand why some prostate cancer tumors stop responding to treatment while others keep shrinking in the same patient. Researchers will use a series of specialized PET scans on 45 men with advanced prostate cancer to track individual tumors over time during standard therapies. The goal is to learn how cancer evolves resistance, which could help guide future, more personalized treatment decisions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MCRPC (METASTATIC CASTRATION-RESISTANT PROSTATE CANCER) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Québec-Université Laval

    RECRUITING

    Québec, Quebec, G1J1Z4, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.